TELUS Reports Third Quarter 2026 Results, Demonstrates Continued Discipline in Core Telecom; Advances Transformation Strategy

TELUS reported a C$660 million Q3 2026 net loss, including a non-cash C$800 million goodwill impairment at TELUS Health; adjusted net income fell 32% to C$251 million and adjusted EBITDA declined 5% to C$1.76 billion (2% excluding specified prior-year items). The company reaffirmed 2026 guidance and launched a multi-year efficiency program targeting approximately C$900 million in annualized cash savings exiting 2028, while targeting net debt to adjusted EBITDA of 3.0x or lower by year-end 2028 versus 3.6x at quarter-end. Core mobile network revenue grew 1%, but consolidated service revenue declined 1% to C$4.5 billion, with TELUS Digital weakness weighing on results.

Analysis

TELUS’s key risk is not the non-cash impairment itself, but what it signals: the Health portfolio’s expected recovery value has weakened just as management prioritizes a sale. A disposal may reduce leverage, but a lower-than-book sale price would crystallize the reset and make the 2028 leverage target more dependent on Telecom execution. Treat the $900 million savings target as an ambition, not near-term earnings support: timing, implementation costs and whether savings are genuinely incremental matter, particularly with restructuring cash outlays elevated and quarterly free cash flow under pressure.

Near term, stable mobile ARPU/churn and stronger fixed-data trends are constructive, but they do not yet offset Digital’s hyperscaler-related volume losses or legacy-service erosion. Automation is a structural headwind to TELUS Digital and traditional customer-experience outsourcing; hyperscalers and buyers of automated services may benefit, while vendors relying on labor-intensive service volumes face repricing risk. TELUS’s fibre connectivity could benefit third-party data centres, but the company’s stated preference for partnerships over balance-sheet-intensive shell development is the right constraint while leverage remains high. The AST SpaceMobile reference provides no new commercial economics or commitment; it is not a trade signal for ASTS.

Over 1–3 months, watch Health/Agriculture sale terms, free-cash-flow conversion and management’s quantified savings milestones. Over 6–18 months, the test is whether Telecom can deliver savings without degrading retention or network quality. Contrarian point: the impairment is non-cash, but the portfolio valuation reset and weak adjusted earnings/cash flow make it unsafe to dismiss as merely accounting. Reaffirmed guidance is not evidence of a stronger trajectory. A material asset sale at acceptable proceeds and improving organic FCF would weaken the cautious view; missed guidance, deteriorating churn or a leverage path reliant on unclosed divestitures would strengthen it.

Key Decisions for Investors

• Keep TELUS (T) underweight versus a Canadian telecom peer basket; do not add on the non-cash-loss framing alone. Reassess if two consecutive quarters show improving free cash flow alongside stable mobile churn and ARPU.
• Treat the announced savings as unproven until TELUS reports realized, incremental run-rate savings net of restructuring cash costs. Flag delays, rising costs, or evidence of customer-care deterioration as thesis-confirming.
• For credit, avoid adding duration or spread exposure without reviewing current bond spreads, maturities and covenant headroom. Revisit only alongside verifiable asset-sale proceeds and a credible quarterly leverage trajectory toward the 2028 target.
• Monitor Health and Agriculture divestiture terms: compare proceeds with carrying values and assess how much debt is actually repaid. Weak proceeds or delayed transactions would undermine the deleveraging thesis.
• No ASTS position: the disclosed connectivity relationship lacks new deployment, revenue, or investment details. Revisit only on a quantified commercial agreement or material capital commitment.